SABS(SABS)
SABS
ANALYST COVERAGE7 analysts
BUY
▲ +156.4%upside to target
L $7.00
Med $10.00consensus
H $11.00Key MetricsTTM
Market Cap$37.28M
Revenue TTM—
Net Income TTM—
Free Cash Flow—
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-0.3%
Return on Assets-0.2%
Debt / Equity—
Current Ratio11.45
EPS TTM—
PRICE
Prev Close
3.81
Open
3.85
Day Range3.85 – 3.97
3.85
3.97
52W Range1.60 – 6.60
1.60
6.60
46% of range
VOLUME & SIZE
Avg Volume
789.7K
FUNDAMENTALS
P/E Ratio
-6.7x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.50
Low vol
TECHNICAL
RSI (14)
56
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 24
DEx-Dividend
In 90 days
Aug 21
PDividend Pay
In 128 days
Sep 28
SABS News
About
No description available.
Hua WuSenior Vice President of Product Development
Lucy ToExecutive Vice President & Chief Financial Officer
Christoph BauschExecutive Vice President & Chief Operating Officer
Eddie Joe SullivanCo-Founder, President & Director
Samuel J. ReichCEO & Director
Angie ParizekSenior Vice President of Clinical Operations
Cristi BarnettVice President of Investor Relations & Corporate Communications
Alexandra KropotovaExecutive Vice President & Chief Medical Officer
Carlos N. CarilloSenior Vice President of Regulatory Affairs
Catherine DeRoseVice President of Human Resources